Close Menu

In this week's Nature, University of California, Berkeley scientists and others investigate a new CRISPR nuclease — dubbed CasX — that can edit the human genome with different functionality than Cas9 and Cas12a. CasX was isolated from groundwater microbes and is smaller than other CRISPR nucleases at fewer than 1,000 amino acids. The authors show that CasX can modify both human and E.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.